Literature DB >> 7725531

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.

D Niese1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7725531

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.

Authors:  T E Jones
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

Review 2.  Clinical use of cyclosporin in rheumatoid arthritis.

Authors:  C Richardson; P Emery
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 3.  Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.

Authors:  A J Coukell; G L Plosker
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

Review 4.  Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.

Authors:  C J Dunn; A J Wagstaff; C M Perry; G L Plosker; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Cost evaluation of basiliximab treatment for renal transplant patients in Japan.

Authors:  Tomonori Hasegawa; Hidehiko Imai; Sunao Miki
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 6.  Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

Authors:  S Noble; A Markham
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.